Dr Aidan Flynn
Honorary Fellow
Melbourne Medical School
15 Scholarly works
2 Projects
HIGHLIGHTS
2026
Research grants (ARC, NHMRC, MRFF)
Development of a Multi-Omic Liquid Biopsy Test for Cancer of Unknown Primary
2025
Journal article
762MO Clinical whole genome and transcriptome sequencing for cancer of unknown primary: An Australian prospective observational study
DOI: 10.1016/j.annonc.2025.10.11772025
Journal article
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary
DOI: 10.1038/s41467-025-59661-x2025
Journal article
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles
DOI: 10.1038/s41467-025-57595-y2024
Journal article
Somatic CpG hypermutation is associated with mismatch repair deficiency in cancer
DOI: 10.1038/s44320-024-00054-52023
Research contracts (non-grants)
Review of Proposed Template for a Data Access Agreement
2022
Journal article
Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment
DOI: 10.1038/s41467-022-34011-3
RECENT SCHOLARLY WORKS
2022
Conference Proceedings
Deconvolution of immunotherapy-treated glioblastoma identifies cellular heterogeneity and plasticity at the single-cell level
DOI: 10.1093/neuonc/noac174.1252022
Journal article
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study
DOI: 10.1002/1878-0261.130152021
Conference Proceedings
TAMI-68. DECONVOLUTION OF IMMUNOTHERAPY-TREATED GLIOBLASTOMA IDENTIFIES CELLULAR HETEROGENEITY AND PLASTICITY AT THE SINGLE-CELL LEVEL
DOI: 10.1093/neuonc/noab196.8502018
Journal article
TERT structural rearrangements in metastatic pheochromocytomas
DOI: 10.1530/ERC-17-03062017
Conference Proceedings
Patterns of Referral to Palliative Care in Patients Receiving Chemotherapy